Richard Sullivan/LinkedIn
Apr 10, 2025, 11:14
Richard Sullivan: What is the role for China reshaping Global Health for a low-cooperation world?
Richard Sullivan, Professor of Cancer and Global Health at King’s College London, shared an article by Mark P Lythgoe, et al. on LinkedIn:
“China has had one of the most rapid health and cancer transitions in the world.
A parallel drive around cancer R&D has led to impressive results in a wider range of cancer technologies, particularly immuno-oncology. But China has moved well beyond domestic boundaries to embrace global health and development.
In our new analysis we explore what role China may have in reshaping global health in an increasingly contested world.”
The rise of immuno-oncology in China: a challenge to western dominance?
Authors: Mark P Lythgoe, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:38
May 29, 2025, 22:26